Get Your Personalized Supplement StackSupplement Stack Quiz

Organic Ginkgo Powder

Also known as: Ginkgo, Maidenhair tree, Organic Ginkgo Powder, Ginkgo biloba L.

Overview

Organic Ginkgo Powder is derived from the dried leaves of the Ginkgo biloba tree, a species native to China. It is widely recognized as a herbal extract and botanical supplement, primarily used for its potential to improve cognitive function, memory, and blood circulation. The powder contains bioactive compounds, specifically flavonoids and terpenoids, which are believed to be responsible for its health benefits. It is often consumed in capsule or powder form, with standardized extracts ensuring consistent levels of active compounds. Extensive research, including numerous randomized controlled trials and meta-analyses, has explored its effects on cognitive function, dementia, Alzheimer’s disease, diabetic kidney disease (DKD), and schizophrenia symptom management. While some high-quality meta-analyses support modest cognitive benefits, the overall evidence quality is mixed due to methodological variability.

Benefits

Ginkgo biloba has demonstrated several evidence-based benefits. For cognitive function in Alzheimer’s disease, a meta-analysis of four randomized controlled trials (n=424) indicated a small but statistically significant improvement in objective cognitive measures after 3-6 months of 120-240 mg daily supplementation, with an effect size of approximately 0.41. This suggests less than half a standard deviation improvement compared to placebo. A systematic review and meta-analysis also showed that Ginkgo biloba reduced positive symptoms in schizophrenia and improved cognitive function and activities of daily living in dementia patients, with standardized mean differences ranging from -0.49 to -2.89 depending on the outcome. Furthermore, a recent meta-analysis of RCTs found that Ginkgo biloba extract, when combined with conventional renin-angiotensin-aldosterone system inhibitors, showed efficacy and safety as an adjunct therapy in patients with diabetic kidney disease (DKD). The benefits typically manifest after at least three months of continuous supplementation, with effect sizes generally being small to moderate.

How it works

Ginkgo biloba exerts its effects through multiple biological pathways. Its primary mechanisms include potent antioxidant and anti-inflammatory actions, which help protect cells from damage. It also modulates blood flow by promoting vasodilation, thereby improving microcirculation, particularly in the brain. Neuroprotective effects are attributed to its ability to scavenge free radicals and inhibit platelet-activating factor. The active compounds, flavonoids and terpenoids, interact with various neurotransmitter systems and the vascular endothelium. These actions collectively contribute to cognitive enhancement in the central nervous system, improved microcirculation in the cardiovascular system, and beneficial adjunctive effects in the renal system, as seen in DKD.

Side effects

Ginkgo biloba is generally well tolerated at doses up to 240 mg/day, though long-term safety data are mixed. Common side effects, occurring in more than 5% of users, include mild gastrointestinal discomfort, headache, and dizziness. Uncommon side effects (1-5%) may involve allergic skin reactions and palpitations. Rare side effects (less than 1%) include an increased risk of bleeding due to its platelet-inhibiting properties. Animal studies at very high doses have indicated potential hepatotoxicity, though this is not typically observed in human use at recommended dosages. Ginkgo biloba should be used with caution alongside anticoagulants and antiplatelet drugs due to the heightened bleeding risk. It is contraindicated in individuals with bleeding disorders, those undergoing surgery, and pregnant or lactating women without medical advice. While primarily used by the elderly and those with cognitive decline, its safety in children has not been established.

Dosage

The minimum effective dose for Ginkgo biloba standardized extract is approximately 120 mg per day. The optimal dosage range is typically 120-240 mg per day, often divided into two or three doses. Doses up to 240 mg/day are commonly used and considered safe, but higher dosages should only be taken under medical supervision. For benefits to manifest, consistent daily dosing for at least three months is usually required. It is crucial to use standardized extracts containing 24% flavone glycosides and 6% terpene lactones. Taking Ginkgo biloba with food may enhance absorption. While no specific cofactors are required, other antioxidants might have synergistic effects. There are no specific upper limits beyond the commonly used 240 mg/day, but caution is advised with higher doses.

FAQs

Is Organic Ginkgo Powder safe long-term?

Generally, yes, but prolonged use, especially at higher doses, warrants monitoring for potential bleeding risks and liver effects. Consult a healthcare professional for long-term use.

How soon do effects appear?

Cognitive benefits typically manifest after at least three months of consistent daily supplementation. It is not an immediate-acting supplement.

Can it be taken with blood thinners?

It is not recommended to take Ginkgo biloba with blood thinners (anticoagulants or antiplatelet drugs) without explicit physician approval due to an increased risk of bleeding.

Does it cure dementia or Alzheimer’s?

No, Ginkgo biloba does not cure dementia or Alzheimer’s disease. It may, however, modestly improve symptoms or slow cognitive decline in some individuals.

Research Sources

https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1408546/full – This meta-analysis of randomized controlled trials investigated Ginkgo biloba extract as an adjunct therapy for diabetic kidney disease (DKD). It found that combining Ginkgo biloba with conventional renin-angiotensin-aldosterone system inhibitors improved renal outcomes and was safe, with subgroup analyses considering various factors. The study was registered with PROSPERO and assessed using GRADE, indicating high quality.
https://jamanetwork.com/journals/jamaneurology/fullarticle/774397 – This meta-analysis of four randomized controlled trials in Alzheimer's patients found a small but statistically significant improvement in objective cognitive measures after 3-6 months of Ginkgo biloba supplementation (120-240 mg/day). The effect size was approximately 0.41, suggesting a modest benefit, though the small number of studies and heterogeneity were noted limitations.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3679686/ – This systematic review and meta-analysis explored the effects of Ginkgo biloba on schizophrenia and dementia. It concluded that Ginkgo biloba reduced positive symptoms in schizophrenia and improved cognitive function and activities of daily living in dementia patients, although high heterogeneity and variable outcome measures were identified as limitations.
https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-ginkgo-biloba-l-folium_en.pdf – This final assessment report from the European Medicines Agency (EMA) provides a comprehensive evaluation of Ginkgo biloba L. folium. It confirms the overall safety of Ginkgo biloba when used as directed, contributing to regulatory assessments of its medicinal use.